| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
58.08 |
B.V. (₹) |
369.20 |
| Sales(₹ Cr.) |
10,933.30 |
NP (₹ Cr.) |
1,741.31 |
| NP Var% |
-11.00 |
Div% |
0.00 |
| CPS(₹) |
35.10 |
EPS (₹) |
30.00 |
| Traded Value(₹ Lakhs) |
153.83 |
52 Week High |
1,365.00 |
| 52 Week Low |
994.00 |
Price BSE |
1,194.00 |
| Price NSE |
1,195.00 |
Market Capital (₹ Cr.) |
69,330.29 |
| P/C Ratio |
34.00 |
P/E Ratio |
39.80 |
| Price Vs.BV |
3.23 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
2,759.89 |
| NP(₹ Cr.) |
581.37 |
NP Var % |
8.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
10,713.37 |
| OPM |
23.11 |
NP |
2,069.02 |
| NP Var% |
-2.33 |
EPS |
34.79 |
| PE |
34.31 |
|
|